Autoinjectors Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030

The global market value of the autoinjectors market was valued at USD 54.2 billion in 2022, and a CAGR of 18.1% is expected during the forecast period. These are devices designed to deliver a single dose of a particular medication. These are often used in emergency situations, such as severe allergic reactions or conditions like diabetes. The user-friendly nature of autoinjectors is the reason behind their growing market. It comes with pre-filled cartridges, making them convenient for quick administration of medication.

The rising prevalence of chronic diseases and advancements in biologics are driving significant growth in the market. Increasing awareness about self-administration is leading to a higher demand for autoinjectors. Ongoing improvements in its design are driving growth in the market significantly. The growing aging population requires regular medication for chronic conditions, driving the demand for autoinjectors. Rising healthcare expenditures globally allow for greater investment in innovative drug delivery devices like autoinjectors.

Impact of Covid-19

Covid-19 has had a mixed impact on autoinjectors market. With concerns about visiting healthcare facilities, during the pandemic, there has been a heightened interest in self-administration of medications, leading to a potential increase in demand for autoinjectors. Telemedicine became more prevalent during the pandemic, and autoinjectors are well suited for use in remote healthcare settings, facilitating remote consultation. Though lockdown, travel restrictions, and disruptions in global supply chain have led to the challenges in the production, distribution, and availability of autoinjectors. During the pandemic, the healthcare resources were redirected towards managing covid-19 cases leading to delays or cancellation in non-urgent medical treatments, which could have affected the demand for autoinjectors for chronic conditions. Economic uncertainties caused due to pandemic has led to reduced spending on healthcare sector, impacting the affordability of autoinjectors. Long term outlook for this market remains positive, driven by the factors such as rising prevalence of chronic diseases.

Growth Drivers

The increasing prevalence of chronic diseases worldwide is driving significant growth in the autoinjector market. Rising healthcare expenditures in growing economies are driving the demand for autoinjectors. With the rising elderly population globally, there is a greater need for a user-friendly drug delivery system. Autoinjectors cater to this demographic by offering ease of use and reducing dependency on healthcare providers for injections. The shift towards homecare settings for disease management is boosting the demand for autoinjectors.

The growing use of biologic drugs for various chronic conditions necessitates precise and controlled delivery mechanisms, driving the adoption of autoinjectors. Favorable regulatory policies for self-administration with the help of autoinjectors are significantly contributing to market growth. Increasing investment in healthcare in emerging economies and developed countries is driving growth in the autoinjector market. The benefits of autoinjectors in emergency medical care are driving the demand for autoinjectors in the market significantly.

Increasing lucrative opportunities from Asia, the Pacific, and the European markets are driving the growth significantly. The rising production of self-injection devices by key players is boosting the production of advanced devices across the globe and raising the growth in revenue generated by the market significantly. The key players are now trying to emphasize adding new devices to their existing product portfolio to enable patients to utilize the feature of self-administration. 

Segmentation

By Type

·         Disposable

·         Reusable

By Application

·         Autoimmune disorder

·         Diabetes

·         Emergency Care

·         Others

By Route of Administration

·         Intramuscular

·         Subcutaneous

By Distribution Channel

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies

Regional Outlook

·         Asia Pacific

·         North America

·         Latin America

·         Europe

·         Middle East and Africa

Autoinjectors Market by Type Segmentation

On the basis of type, the autoinjector market is segmented into disposable and reusable. Disposable is the leading segment and is expected to dominate the market during the forecast period. Disposable autoinjectors are environment-friendly and are expected to increase revenue.

Autoinjectors Market by Application Segmentation

On the basis of the application, the autoinjector market is segmented into autoimmune disorders, diabetes, and emergency care. Increasing demand for insulin, which is injectable, led to diabetes segment growth. By application, diabetes is the leading segment and is expected to dominate the market during the forecast period.

Regional Outlook

On the basis of the regions, the autoinjectors market is segmented into 5 parts: Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. North America is the leading segment because it is a hub for technological innovations. Many companies in the region invest heavily in research and development, leading to the introduction of advanced autoinjector technology. The increasing number of cases of chronic diseases in the region is driving significant growth in the market.

The healthcare infrastructure in North America, including insurance coverage and accessibility to healthcare services, makes autoinjectors more widely available and affordable compared to other regions. A stringent regulatory framework in North America ensures the safety and efficacy of medical devices, including autoinjectors. This regulatory environment fosters trust among healthcare providers and patients, driving the adoption of these devices. There is a growing trend towards self-administration among patients in North America, driven by convenience, autonomy, and improved quality of life. Autoinjectors offer a user-friendly solution for self-administration, contributing to their popularity in the region.

Europe is a major player in the autoinjectors market, with countries like Germany, the UK, France, and Italy being key contributors. Europe has a high prevalence of chronic disease, and the increasing geriatric population is driving growth in the region. Increasing awareness of self-administration devices among patients is driving the demand for autoinjectors in the market significantly.

The Asia Pacific region is experiencing rapid growth in the autoinjector market, driven by factors like a large population base, rising healthcare expenditure, increasing prevalence of chronic diseases, and increasing healthcare infrastructure in countries like Japan, China, South Korea, and Australia, which are key markets in the region. Rising disposable income in the region is the main cause behind the growth in the Asia-Pacific market. With the evolution of healthcare systems in the region, the market is witnessing significant growth. Both markets—Europe and Asia Pacific—present lucrative opportunities for the autoinjector market.

Key Players

·         Becton

·         Dickinson and Company

·         Novartis AG

·         Merck KGaA

·         Pfizer

·         Philip Medisize

·         Oval medical technologies ltd

·         Viatris Inc

·         Biogen

·         Amgen Inc

·         Eli Lilly and Co.

·         Solteam Incorporation Company Limited

·         Antares Pharma Inc

·         AbbVie Inc

·         Other Players